Summary
The main objective was to develop a scoring system for easy use by the physician in daily clinical practice in deciding the appropriate treatment for his herpes zoster patient. Data from 635 patients who did not receive antiviral therapy were included in this analysis. Of these, 131 developed postherpetic neuralgia (PHN). Of the 29 variables tested univariately in this study, 15 showed a significant correlation with the incidence of PHN, but only six proved to contribute to the overall predictive power in the multivariate approach. Using two independent approaches, the model showed a very satisfactory performance in the validation sample. Patients without acute pain rarely developed PHN. In those with acute pain, being female, being over 50 years of age, having more than 50 lesions, having lesions of a hemorrhagic nature, having cranial or sacral localisation of the rash or having pain in the prodromal phase proved to be significant, multivariate factors. An easy-to-use scoring system used in a risk graph is proposed. These data should be useful in the individual treatment decision as well as in the design and analysis of therapeutic trials in herpes zoster.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Straus, S. E.: Varicella-zoster virus infections. Biology, natural history, treatment and prevention. Ann. Int. Med. 108 (1988) 221–237.
Gilden, D.H.: Herpes zoster with postherpetic neuralgia_— persisting pain and frustration. N. Engl. J. Med. 13 (1994) 932–934.
Portenoy, R. K., Duma, C., Foley, K. M.: Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann. Neurol. 6 (1986) 651–664.
Davies, L., Cossins, L., Bowsher, D., Drummond, M.: The cost of treatment for post-herpetic neuralgia in the UK. Pharmacoecon 6 (1994) 142–148.
Kost, R. G., Straus, S. E.: Postherpetic neuralgia_— pathogenesis, treatment, and prevention: review article. N. Engl. J. Med. 335 (1994) 33–42.
Meister, W., Neiß, A., Gross, G., Dörr, W., Höbel, W. Malin, J.-P., von Essen, J., Reimann, B.-Y., Witke, C., Wutzler, P.: Epidemiology of zoster in ambulatory patients. Intervirology (in press).
Harrel, F. E., Lee, K. L., Matchar, D. B., Reichert, T. A.: Regression models for prognostic prediction: advantages, problems and suggested solutions. Canc. Treat. Rep. 69 (1985) 1071–1077.
Hanley, J. A., McNeil, B. J.: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29–36.
Metz, C. E.: Basic principles of ROC analysis. Sem. Nucl. Med. 8 (1978) 283–398.
Bowsher, D.: Post-herpetic neuralgia in older patients; incidence and optimal treatment. Drugs Aging 5 (1994) 411–418.
Hope-Simpson, R. E.: Postherpetic neuralgia. J. R. Coll. Gen. Pract. 25 (1975) 571–575.
Dworkin, R., Boon, R., Griffin, D.: Covariates in herpes zoster and interpretation of clinical trial data. Antiviral Res. 26 (1995) A344.
Tyring, S., Rick, A., Nahlik, J. E., Cunningham, A., Marlex, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R. andthe Collaborative Ficiclovir Herpes Zoster Study Group: Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann. Int. Med. 123 (1995) 89–96.
Beutner, K. R., Friedman, D. J., Forszpaniak, C., Andersen, P. L., Wood, M.: Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob. Agents Chemother. 37 (1995) 1546–1553.
Choo, W.: Risk factors for postherpetic neuralgia. Arch. Intern. Med. 157 (1997) 1217–1224.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Meister, W., Neiß, A., Gross, G. et al. A prognostic score for postherpetic neuralgia in ambulatory patients. Infection 26, 359–363 (1998). https://doi.org/10.1007/BF02770836
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02770836